U.S. Markets for Addictions and Substance Abuse Treatments and Diagonostics
January 23, 2009
Wellesley, Mass—According to a new technical market research report, U.S. MARKETS FOR ADDICTIONS AND SUBSTANCE ABUSE TREATMETS AND DIAGNOSTICS (PHM035B) from BCC Research (www.bccresearch.com), the U.S market for addictions and substance abuse treatment and diagnostics generated $2.7 billion in 2008. This is expected to increase to $3.1 billion in 2013, for a compound annual growth rate (CAGR) of 2.7%.
The market is divided into the major segments of pharmaceutical treatments and diagnostic testing. Pharmaceutical treatments have the largest market share, generating $2.5 billion in 2008. This should increase to almost $2.8 billion in 2013, for a CAGR of 2.3%.
The diagnostic testing segment is the second largest and was worth $230.0 million in 2008. This is expected to increase at a CAGR of 5.9% to reach $307.0 million in 2013. This segment accounts for approximately 8% of the market.
The testing market should continue to show moderate growth due to advancements in technology, making testing more accessible and easy to accomplish. Growth also will be fueled by advancements in quality and design, helping to make the tests more accurate and cost effective, and by increasing trends in the general public, as individuals take greater responsibility for health care. The need for instant results, at an affordable price, will also help the substance abuse diagnostic testing industry to grow.
It is evident that the relapse rate for addiction is significant and that pursuing products that address not only the acute conditions of addiction but also continued treatment, perhaps for a lifetime, are needed. Since addiction seems to be a multidisciplinary problem, the focus of treatment needs to be broadened as is evident in select new products that are in development for drug addiction. Companies that are operating in this arena will need to continue to advance products that tackle all facets of the addiction process to be successful.
U.S. Markets for Addiction & Substance Abuse Treatment( PHM035B )
Publish Date: Jan 2009
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Pharmaceuticals
- Global Bispecific Antibodies Market to Reach $22.3 Billion by 2030 as Immuno-Oncology Innovation and R&D Investment Accelerate
- Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
- Radioligand Therapeutics Market to More Than Double to $4.8 Billion by 2030 as Targeted Cancer Treatments Gain Regulatory Momentum
- Global GLP-1 Analogues Market to Reach $268.4 Billion by 2030
- AI in Clinical Trials Poised for Rapid Growth with a 22.6% CAGR Forecast
Reports from Pharmaceuticals
Recent News
- Biometrics as a Service in Medical Devices to Reach $2.7 Billion by 2030, Driven by Remote Patient Monitoring Demand
- Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
- AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
- Global Noninvasive Cancer Diagnostics Market to Reach $165.2 Billion by 2030 as Liquid Biopsy, AI-Enabled Screening and Multi-Cancer Detection Tests Transform Oncology
- Cloud Computing in Cell Biology, Genomics and Drug Development to Reach $15.6 Billion by 2030 as Biological Data Explosion Drives Demand